Indicated for: cancer
Route of administration: infusion
Substance: fotemustine (antineoplastic agent)
ATC: L01AD05 (Antineoplastic and immunomodulating agents | Alkylating agents | Nitrosoureas)
Fotemustine is a cytostatic medication used in the treatment of certain types of cancer, especially advanced malignant melanoma and some brain tumors. It works by inhibiting the division of cancer cells, slowing down or stopping their growth in the body.
Fotemustine is administered intravenously under strict medical supervision, usually in a hospital or oncology center. The dose and treatment schedule are determined by the doctor based on the type and stage of cancer, as well as the patient's general condition.
Side effects may include a decrease in blood cell counts, nausea, vomiting, fatigue, infections, or impaired liver function. In some cases, allergic reactions or lung problems may occur. Careful monitoring is essential throughout the treatment.
Fotemustine is an effective medication for certain forms of cancer, but its use involves risks and requires continuous medical supervision. Follow your doctor's instructions closely and report any unusual symptoms to prevent complications.